Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Colorectal Cancer Metastatic × Lycopene × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 6 Male Urogenital Diseases 3 Uremia 1 Prostatic Intraepithelial Neoplasia 1 Disease Progression 1 Colorectal Cancer Metastatic 1 Carcinoma, Transitional Cell 1

Interventions

Fluorouracil 7 Capecitabine 7 Bevacizumab 7 Oxaliplatin 6 Leucovorin 6 Irinotecan 6 Cetuximab 5 Panitumumab 4 sintilimab 2 regorafenib 2 aflibercept 2 spartalizumab 1 pembrolizumab 1 irinotecan sucrosofate 1 camrelizumab 1 atezolizumab 1 anisodamine 1 SHR-1701 1 Radiotherapy 1 Pemetrexed 1 Nivolumab 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Methotrexate 1 Lycopene 1 Loperamide 1 Ipilimumab 1 HMPL-013 1 Gemcitabine 1 Drug Therapy 1 Dexamethasone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03167268 2021-09-09

PaSTo

Ospedale San Carlo Borromeo

Phase 2 Unknown

Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡